Enter assignee name

% Expired Patents = 20.0

Trademarks = 3

Forward Citations = 25

Loading Chart...

16 inventors (with patents filed for the assignee):

Sylvia Miescher (2 out of 11 patents)

Andreas Morell (2 out of 3 patents)

Martin Imboden (2 out of 3 patents)

4. Monique Vogel (2 out of 5 patents)

5. Hanspeter Amstutz (2 out of 3 patents)

6. Beda Stadler (2 out of 5 patents)

7. Reinhard Franz Bolli (1 out of 18 patents)

8. Peter Lerch (1 out of 10 patents)

9. Christoph Thiemermann (1 out of 5 patents)

10. Gerhard Hodler (1 out of 5 patents)

11. Regula Styger (1 out of 3 patents)

12. Gillian Cockerill (1 out of 2 patents)

13. Thomas Luescher (1 out of 1 patent)

14. Georg Noll (1 out of 1 patent)

15. Norman Miller (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 8906368 - Immunoglobulin preparations having increased stability (2014-12-09),

2. 7399471 - Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use (2008-07-15),

3. 7053049 - Method for treating unstable angina pectoris (2006-05-30),

4. 7038020 - Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use (2006-05-02),

5. 6998388 - High density lipoprotein against organ dysfunction following haemorrhagic shock (2006-02-14),

Zlb Behring Ag is a leading pharmaceutical company specializing in innovative therapies for a wide range of medical conditions. With a strong focus on research and development, Zlb Behring Ag is committed to improving patient outcomes and quality of life. They offer a diverse portfolio of products and services, and strive to make a positive impact on healthcare worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

5 Patents

#30 in Bern

#1,701 in Switzerland

Bern, Switzerland

Zlb Behring Ag